The National Institutes of Health, Office of Dietary Supplements released their annual Annual Bibliography of Significant Advances in Dietary Supplement Research. The 2006 Annual Bibliography highlights emerging findings from a diverse array of laboratory and human studies. These include the potentially favorable effects of resveratrol as an anti-inflammatory compound.
The paper chosen regarding resveratrol, which was selected from 2006 was “Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells: Role of NF-κB inhibition.” Which suggested the anti-inflammatory effects of resveratrol are responsible at least in some part for its cardio protective effects, although they also suggest that additional research on resveratrol will need to study the mechanisms by which resveratrol exerts its effects.
Funding for this resveratrol study was by the National Heart, Lung, and Blood Institute, NIH; American Heart Association; Philip Morris USA; and Philip Morris International.
Related posts: